Top-funded digital health companies offering lifestyle interventions for dementia prevention: Company overview and evidence analysis
Our study shows that the level of funding received by companies does not reflect the clinical effectiveness of DDLS. The study serves as an initial step toward understanding how DDLS are currently evaluated in today's market and highlights the need for a more rigorous evaluation of DDLS effectiveness.
Authors
- Marcia Nißen (ORCID: https://orcid.org/0000-0002-6082-8825)
- Rasita Vinay (ORCID: https://orcid.org/0000-0002-0490-5697)
- Tobias Kowatsch (ORCID: https://orcid.org/0000-0001-5939-4145)
- Mathias Schlögl (ORCID: https://orcid.org/0000-0002-6299-8852)
- Panitda Huynh (ORCID: https://orcid.org/0000-0002-1169-2271)
- Jonas Probst
Institutions
- University of Zurich (CH)
- University of St.Gallen (CH)
- ETH Zurich (CH)
- Klinik Barmelweid (CH)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-05-05
- DOI
- https://doi.org/10.1371/journal.pone.0323390
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00